2m 2m 2m 2m 2m 2m 2m
ACRIVON THERAPE (ACRV)
NASDAQ
$1.63+$0.06 (+3.76%)
Price as of Nov 11, 2026 7:30 PM EST- $67.3MMarket Cap
- -24.15%1-Year Change
- BiotechnologyIndustry
ACRIVON THERAPE (ACRV)
$1.63+$0.06 (+3.76%)
Earnings Score
Valuation | ACRV | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -0 | ||
Low Earnings Volatility | N/A |
Momentum Score
Valuation | ACRV | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 9.20% | ||
12-Month Momentum | -6.40% | ||
3-Month Risk Adjusted Momentum | 29.24% | ||
12-Month Risk Adjusted Momentum | -7.56% |
True Yield
Valuation | ACRV | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | ACRV | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | -2 |